Clinical trials: Generic Drug Quality
Behaviour Change
Targeted Vs Generic Print Materials on Physical Activity and Quality of Life in Young Adult Cancer Survivors
Young adult cancer survivors (YACS) are an understudied group in cancer survivorship research that have unique psychosocial, medical and survivorship issues.
- Trial name
- NCT05450315
- Testing
- Stride to Survive:An Exercise Guide for Young Adult Cancer Survivors, Canadian Physical Activity Guidelines
- Where
- Canada
- Volunteers
- 212 people, healthy volunteers welcome
- Sponsor
- University of Alberta
Rotator Cuff Tear
Quality of Life After Arthroscopic Rotator Cuff Repair
The goal of this longitudinal study is to understand the postoperative quality of life and dynamic trajectory of shoulder function in individuals with rotator cuff tears.
- Trial name
- NCT06120998
- Testing
- Arthroscopic rotator cuff repair
- Where
- Taiwan
- Volunteers
- 201 people
- Sponsor
- Chang Gung Memorial Hospital
Generic Drug Quality, Generic Formulation Interchangeability
Generic Formulations of Commonly-used Oral Drugs in Saudi Arabia:Interchangeability & Post-marketing Quality
Generic formulations of prescription drugs can, through their relatively lower cost, improve healthcare as long as they maintain their registration-quality and public trust.
- Trial name
- NCT01344070
- Testing
- one of the 15 drugs listed below
- Where
- Saudi Arabia
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- King Faisal Specialist Hospital & Research Center
Malignant Melanoma
Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)
The primary objective for this non-interventional study was to assess the quality of life of melanoma patients under adjuvant treatment with dabrafenib and trametinib in real world setting in Portugal through disease specific…
- Trial name
- NCT04547946
- Testing
- dabrafenib + trametinib
- Where
- 2 sites in Portugal
- Volunteers
- 3 people
- Sponsor
- Novartis Pharmaceuticals
Relapsing Remitting Multiple Sclerosis
Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA Region
The purpose of this observational study is to evaluate the effectiveness, safety and health related quality of life of Generic DMF (Sclera® or Marovarex ®, Hikma) in patients undergoing routine clinical care for RRMS in MENA…
- Trial name
- NCT04468165
- Testing
- Dimethyl Fumarate (DMF)
- Where
- 6 sites in Algeria, Egypt and 1 more
- Volunteers
- 160 people
- Sponsor
- Hikma Pharmaceuticals LLC